Interview with EPS President Noriyuki Takai Featured in The Worldfolio
The Worldfolio has published an interview with Noriyuki Takai, Representative Director and President of EPS Corporation.
The Worldfolio publishes interviews and reports focusing on countries and regions around the world. This interview was conducted as part of a special report on Japan.
In the interview, Takai discusses the role Japan can play in global drug development, reflecting on the evolving pharmaceutical and clinical development landscape in Japan and challenges such as drug lag and drug loss.
The interview also highlights EPS’s strengths in providing support across the drug development lifecycle, from clinical development and regulatory affairs through post-marketing activities, as well as our efforts to support global pharmaceutical and biotechnology companies expanding into Japan and across Asia. It also explores the future of clinical development through the use of AI and digital technologies.
We invite you to read the full interview.
▼ Read the full interview
How EPS Corporation Is Advancing Clinical Development Across Japan and Asia
Contact Us
Share this page